Let me start this by stating that I rarely post here and do
Let me start this by stating that I rarely post here and do not post at all on the other site anymore. Too much crap on both sites. I have been buying IPIX/CTIX for 4 years now and have not sold any shares that I have acquired. I originally entered for the Kevetrin potential but have been very happy with the Prurisol and Brilacidin development. I work in oral health and have treated oral mucositis cases over the years but none recently. If the case reaches severe, which they often do, then the patient is in such distress that complying with a study regimen which does not seem to be improving their condition and which involves "swishing" (the exact thing that is extremely painful for them) can be unbelievably difficult and is therefore more likely to be terminated. Obviously this could also apply to any patient in this Brilacidin study who was receiving the medication vs. placebo and not improving but one has to consider that if the medication were working as desired then FEWER WOULD DROP OUT due to the discomfort in the treatment group than in the placebo group. I believe that this is the primary reason for the higher than expected numbers for the placebo group (beyond the fact that the historical range for placebo can fluctuate) which make the response rate for the drug look lower than they could and I believe that those behind the scenes who may now be discussing options/deals/etc. well understand this and will be scrupulously analyzing the data for such possibility. Another thing to consider is that these patients often experience sudden changes in health status even if being helped with an isolated sequela such as OM. Such changes can certainly have an effect on their ability to continue daily activities and these changes would almost certainly be more impactful if the OM were worsening and causing general systemic issues. I believe that Drano has it right in post 39995.
As to formulation for Brilacidin delivery that has been discussed, in oral health often we use a fluconasol vaginal troche (obviously not designed for the oral cavity) for treating oral fungal infections BECAUSE it increases exposure to the oral cavity tissues over that received by liquid fluconasol (swish and swallow). It's not rocket science and could probably be relatively easily accomplished by a partner.
All IPO but I have not sold a single share and expect good things soon.
10
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Top 5 Most Recently Viewed Articles
Collaborative Efforts to Address Hypertension Hypertension is a critical health issue affecting millions of adults each year across the nation. In light of this, a significant collaboration has emerged between MedCerts and the American Medical Association (AMA) aimed at enhancing blood pressure measurement skills among healthcare professionals. The urgency of this...
Continue Reading
Empowering LGBTQIA+ Youth: The First-Ever Summit by REACH LA On September 27, 2025, a transformative event is on the horizon. REACH LA is set to host its inaugural LGBTQIA+ Youth Summit, themed "Back To Our Roots", in collaboration with Emerson College. This summit strives to create a nurturing environment dedicated to the empowerment, creativity, and community building...
Continue Reading
Understanding T-Mobile US's Options Activity Investors have been noticing a significant bullish trend regarding T-Mobile US. Analysis of the recent options trading data reveals that many traders are optimistic. Specifically, our analysis shows that 41% of traders are leaning towards a bullish stance on T-Mobile US, while 25% appear bearish. This mixed sentiment conveys an...
Continue Reading
An In-Depth Look at the Decline of the U.S. Dollar Recent trends regarding the U.S. dollar have caught the attention of market analysts and investors. As the dollar continues to decline, many are keen to explore the factors driving this downturn. The greenback has weakened noticeably, falling about 5% from its peak earlier this year and approaching lows not seen in nearly...
Continue Reading
Group 1’s Big Move in San Antonio Group 1 Automotive isn’t just tinkering around the edges anymore—they’ve rolled out a full-scale rebranding in San Antonio. Now, unless you're blindfolded, you can't miss the Group 1 badge across four dealerships in the area. As of April 2026, some familiar names have disappeared, replaced with Group 1’s own, though the heart of...
Continue Reading